These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22329163)

  • 21. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
    Awasthi N; Schwarz MA; Schwarz RE
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of human O6-methylguanine-DNA methyltransferase by affinity chromatography and tandem mass spectrometry.
    Niture SK; Doneanu CE; Velu CS; Bailey NI; Srivenugopal KS
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1176-84. PubMed ID: 16226712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.
    Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T
    Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.
    Yin D; Xie D; Hofmann WK; Zhang W; Asotra K; Wong R; Black KL; Koeffler HP
    Mol Carcinog; 2003 Jan; 36(1):23-31. PubMed ID: 12503076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum(II) in oral cancer cell lines.
    Maki Y; Murakami J; Asaumi J; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Fukui K; Kawai N; Yanagi Y; Kuroda M; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2005 Nov; 41(10):984-93. PubMed ID: 16043385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of human O6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents.
    Wu ZN; Chan CL; Eastman A; Bresnick E
    Cancer Res; 1992 Jan; 52(1):32-5. PubMed ID: 1727384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
    Tandle AT; Mazzanti C; Alexander HR; Roberts DD; Libutti SK
    Cytokine; 2005 Jun; 30(6):347-58. PubMed ID: 15935955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nickel(II) inhibits the repair of O6-methylguanine in mammalian cells.
    Iwitzki F; Schlepegrell R; Eichhorn U; Kaina B; Beyersmann D; Hartwig A
    Arch Toxicol; 1998 Nov; 72(11):681-9. PubMed ID: 9879805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage.
    Teo AK; Oh HK; Ali RB; Li BF
    Mol Cell Biol; 2001 Oct; 21(20):7105-14. PubMed ID: 11564893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repair of DNA lesion O6-methylguanine in hepatocellular carcinogenesis.
    Major GN; Collier JD
    J Hepatobiliary Pancreat Surg; 1998; 5(4):355-66. PubMed ID: 9931384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts.
    Reznikov AG; Chaykovskaya LV; Polyakova LI; Kornelyuk AI; Grygorenko VN
    Exp Oncol; 2011 Dec; 33(4):231-4. PubMed ID: 22217713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of localization of human DNA repair enzyme O6-methylguanine-DNA methyltransferase at active transcription sites in transcription-repair coupling of the mutagenic O6-methylguanine lesion.
    Ali RB; Teo AK; Oh HK; Chuang LS; Ayi TC; Li BF
    Mol Cell Biol; 1998 Mar; 18(3):1660-9. PubMed ID: 9488483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of O6MeG lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity.
    Martin L; Marples B; Coffey M; Lawler M; Hollywood D; Marignol L
    Radiat Res; 2009 Oct; 172(4):405-13. PubMed ID: 19772461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The increasing mutagenic effect of nitrosoguanidine under the influence of modified bases during inhibition of repair AGT enzyme in mammalian somatic cells in vitro].
    Lukash LL; Lylo VV; Man'ko VG; Terent'ev AG
    Tsitol Genet; 2002; 36(3):41-50. PubMed ID: 12187853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant progression in O6-methylguanine-DNA methyltransferase-deficient esophageal cancer cells is associated with Ezrin protein.
    Su Y; Liu R; Sheng J; Liu H; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G; Tang D; Yin L
    DNA Cell Biol; 2012 May; 31(5):856-66. PubMed ID: 22196440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT).
    Gefen N; Brkic G; Galron D; Priel E; Ozer J; Benharroch D; Gopas J
    Cancer Biol Ther; 2010 Jan; 9(1):49-55. PubMed ID: 19946217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of O6-methylguanine-DNA methyltransferase expression on the drug resistance of clear cell renal cell carcinoma.
    Ge N; Guo L; Zhang J; Lin Z; Li Y; Liu Y; Kong F; Fang X; Zhao S
    Jpn J Clin Oncol; 2015 Sep; 45(9):860-6. PubMed ID: 26185135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.